• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不坚持服用他汀类药物的原因——综述的系统评价

Reasons for Nonadherence to Statins - A Systematic Review of Reviews.

作者信息

Ingersgaard Marianne Vie, Helms Andersen Tue, Norgaard Ole, Grabowski Dan, Olesen Kasper

机构信息

Health Promotion, Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Education Department, Steno Diabetes Center Copenhagen, Gentofte, Denmark.

出版信息

Patient Prefer Adherence. 2020 Apr 2;14:675-691. doi: 10.2147/PPA.S245365. eCollection 2020.

DOI:10.2147/PPA.S245365
PMID:32308373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7135196/
Abstract

PURPOSE

Lipid-lowering medications are often prescribed to decrease the risk of micro- and macro-cardiovascular complications related to dyslipidaemia. Despite widespread prescription of lipid-lowering drugs, including statins, adherence to therapy is a challenge worldwide. This systematic review of reviews aimed to conduct a critical appraisal and synthesis of review findings and to provide an overview of the factors that were found to affect adherence to lipid-lowering drugs, focusing on statins, in the reviews.

PATIENTS AND METHODS

A systematic review methodology was used. MEDLINE, Embase, and Epistemonikos databases were searched for relevant publications. AMSTAR 2 criteria were used to assess the quality of the selected publications.

RESULTS

From a total of 763 screened publications, 9 met all inclusion criteria and were included in this synthesis. Several factors were identified as being associated with adherence to lipid-lowering agents. Among them, high socio-economic and educational position, and middle age had a positive effect on adherence to lipid-lowering agents. Contrary, female sex, older and younger age, non-white race, low socio-economic position, high co-payments, being a new statin user, comorbidities, side effects, regimen complexity, type and intensity of statin dose, smoking, alcohol consumption, imperceptible benefits, and medical distrust contributed to non-adherence. The overall quality of the included reviews was considered critically low to moderate.

CONCLUSION

This review of reviews has evaluated the impact of factors on adherence statins. Further research related to modifiable predictors for non-adherence is warranted.

摘要

目的

降脂药物常用于降低与血脂异常相关的微血管和大血管并发症风险。尽管包括他汀类药物在内的降脂药物广泛应用,但在全球范围内,治疗依从性仍是一项挑战。本系统综述旨在对综述结果进行批判性评价和综合分析,并概述在这些综述中发现的影响降脂药物(重点是他汀类药物)依从性的因素。

患者和方法

采用系统综述方法。检索MEDLINE、Embase和Epistemonikos数据库中的相关出版物。使用AMSTAR 2标准评估所选出版物的质量。

结果

在总共763篇筛选出的出版物中,9篇符合所有纳入标准并被纳入本综述。确定了几个与降脂药物依从性相关的因素。其中,高社会经济和教育地位以及中年对降脂药物依从性有积极影响。相反,女性、老年和年轻、非白人种族、低社会经济地位、高额自付费用、新使用他汀类药物、合并症、副作用、治疗方案复杂性、他汀类药物剂量类型和强度、吸烟、饮酒、难以察觉的益处以及对医疗的不信任导致不依从。所纳入综述的总体质量被认为极低至中等。

结论

本综述评估了各因素对他汀类药物依从性的影响。有必要针对不依从的可改变预测因素开展进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ac/7135196/190c8a083c96/PPA-14-675-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ac/7135196/190c8a083c96/PPA-14-675-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ac/7135196/190c8a083c96/PPA-14-675-g0001.jpg

相似文献

1
Reasons for Nonadherence to Statins - A Systematic Review of Reviews.不坚持服用他汀类药物的原因——综述的系统评价
Patient Prefer Adherence. 2020 Apr 2;14:675-691. doi: 10.2147/PPA.S245365. eCollection 2020.
2
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
5
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.用于动脉粥样硬化性心血管疾病一级预防的药物:系统评价概述。
JAMA Cardiol. 2016 Jun 1;1(3):341-9. doi: 10.1001/jamacardio.2016.0218.
6
Predictors of nonadherence to statins: a systematic review and meta-analysis.他汀类药物不依从的预测因素:系统评价和荟萃分析。
Ann Pharmacother. 2010 Sep;44(9):1410-21. doi: 10.1345/aph.1P150. Epub 2010 Aug 11.
7
Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.时间疗法与传统他汀类药物疗法治疗高脂血症的比较。
Cochrane Database Syst Rev. 2016 Nov 26;11(11):CD009462. doi: 10.1002/14651858.CD009462.pub2.
8
Interventions to improve adherence to lipid-lowering medication.提高降脂药物依从性的干预措施。
Cochrane Database Syst Rev. 2016 Dec 21;12(12):CD004371. doi: 10.1002/14651858.CD004371.pub4.
9
Initial non-adherence to lipid-lowering medication: a systematic literature review.降脂药物初始不依从:系统文献回顾。
BMC Prim Care. 2024 Aug 5;25(1):284. doi: 10.1186/s12875-024-02524-z.
10
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation.早期大剂量降脂治疗以避免心脏事件:一项系统评价与经济学评估
Health Technol Assess. 2009 Jul;13(34):1-74, 75-118. doi: 10.3310/hta13340.

引用本文的文献

1
Racial and Ethnic Disparities in Statin Adherence: Insights from the All of Us Research Program.他汀类药物依从性方面的种族和族裔差异:来自“我们所有人”研究项目的见解。
medRxiv. 2025 Aug 28:2025.08.26.25334490. doi: 10.1101/2025.08.26.25334490.
2
Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD: Real-World Prescribing for Lipid-Lowering Therapy.根据美国心脏病学会/美国心脏协会(ACC/AHA)关于动脉粥样硬化性心血管疾病(ASCVD)高危一级和二级预防中降脂治疗指南的真实世界处方:降脂治疗的真实世界处方
Am J Prev Cardiol. 2025 Jul 23;23:101067. doi: 10.1016/j.ajpc.2025.101067. eCollection 2025 Sep.
3

本文引用的文献

1
Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease.系统评价他汀类药物用于心血管疾病一级预防的依从性预测因素。
PLoS One. 2019 Jan 17;14(1):e0201196. doi: 10.1371/journal.pone.0201196. eCollection 2019.
2
Patient beliefs and attitudes to taking statins: systematic review of qualitative studies.患者对服用他汀类药物的信念和态度:定性研究的系统评价。
Br J Gen Pract. 2018 Jun;68(671):e408-e419. doi: 10.3399/bjgp18X696365.
3
A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years.
Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk Reduction.
非他汀类降脂疗法的进展:心血管风险降低策略演变的叙述性综述
Am J Cardiovasc Drugs. 2025 Aug 30. doi: 10.1007/s40256-025-00762-9.
4
Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practice.美国临床实践中重度或极重度高甘油三酯血症成人患者的急性胰腺炎和心血管事件发生率。
Lipids Health Dis. 2025 Jul 28;24(1):252. doi: 10.1186/s12944-025-02658-8.
5
Factors and outcomes associated with adherence to statins among patients with newly diagnosed cardiovascular disease.新诊断心血管疾病患者他汀类药物依从性相关因素及结局
Am J Prev Cardiol. 2025 Jun 9;23:101028. doi: 10.1016/j.ajpc.2025.101028. eCollection 2025 Sep.
6
Newly Started Versus Previously Treated Statin Patients: A Retrospective Cohort Study Comparing Adherence and Persistence with Reference to Cardiovascular Prevention.新开始使用他汀类药物的患者与既往接受过治疗的他汀类药物患者:一项回顾性队列研究,比较心血管预防方面的依从性和持续性。
Pharmaceuticals (Basel). 2025 Apr 27;18(5):634. doi: 10.3390/ph18050634.
7
Reasons for non-acceptance of statin therapy by patients at high cardiovascular risk.心血管疾病高风险患者不接受他汀类药物治疗的原因。
Sci Rep. 2025 May 16;15(1):17014. doi: 10.1038/s41598-025-01930-2.
8
Determinants of medication adherence in patients with diabetes, hypertension, and hyperlipidemia.糖尿病、高血压和高脂血症患者药物依从性的决定因素。
Hormones (Athens). 2025 Feb 20. doi: 10.1007/s42000-025-00631-9.
9
Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease.对发生过早冠状动脉疾病的患者进行预防性降脂治疗及其与医疗保健的相互作用。
JACC Adv. 2024 Oct 16;4(1):101316. doi: 10.1016/j.jacadv.2024.101316. eCollection 2025 Jan.
10
A Systematic Review Uncovering Modifiable Influences on Statin Adherence.一项揭示对他汀类药物依从性可改变影响因素的系统评价
Patient Prefer Adherence. 2025 Jan 4;19:29-48. doi: 10.2147/PPA.S502645. eCollection 2025.
一项针对≥65 岁人群中他汀类药物不依从和停药相关因素的系统评价和荟萃分析。
J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):798-805. doi: 10.1093/gerona/glx256.
4
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.AMSTAR 2:一种用于系统评价的关键评估工具,该系统评价包括医疗保健干预措施的随机或非随机研究,或两者皆有。
BMJ. 2017 Sep 21;358:j4008. doi: 10.1136/bmj.j4008.
5
Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review.老年患者他汀类药物治疗依从性的模式及预测因素:一项系统评价方案
JMIR Res Protoc. 2017 Mar 7;6(3):e39. doi: 10.2196/resprot.7195.
6
Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review.心血管疾病二级预防中药物依从性的卫生系统障碍与促进因素:一项系统评价
Open Heart. 2016 Sep 14;3(2):e000438. doi: 10.1136/openhrt-2016-000438. eCollection 2016.
7
Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review.了解患者对他汀类药物治疗的看法:我们能否设计出更好的血脂异常管理方法?一项文献综述。
Singapore Med J. 2014 Aug;55(8):416-21. doi: 10.11622/smedj.2014099.
8
Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review.药物保险费用分担策略与慢性病患者治疗结果之间的关联:一项系统综述。
PLoS One. 2014 Mar 25;9(3):e89168. doi: 10.1371/journal.pone.0089168. eCollection 2014.
9
Gender and racial disparities in adherence to statin therapy: a meta-analysis.性别和种族差异对他汀类药物治疗依从性的影响:一项荟萃分析。
Am Heart J. 2013 May;165(5):665-78, 678.e1. doi: 10.1016/j.ahj.2013.02.011. Epub 2013 Mar 26.
10
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5.